Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Abstract LB058: Imaging of CD8⁺ cytotoxic T-cells by Zr-89-Df-IAB22M2C PET/MRI: First clinical experience in patients with metastatic cancer

Johannes Schwenck, Dominik Sonanini, Walter Ehrlichmann, Gabriele Kienzle, Gerald Reischl, Pascal Krezer, Ian Wilson, Ron Korn, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Ferdinand Seith, Andrea Forschner, Thomas Eigentler, Lars Zender, Martin Röcken, Bernd Pichler, Lukas Flatz, Manfred Kneilling, Christian la Fougere

Cancer Res (2022) 82 (12_Supplement): LB058.

https://doi.org/10.1158/1538-7445.AM2022-LB058

Published: 15 June 2022

View article titled, Abstract LB058: Imaging of CD8+ cytotoxic T-cells by Zr-89-Df-IAB22M2C PET/MRI: First clinical experience in patients with metastatic cancer

Journal Articles

Abstract 1146: [¹⁸F]FPyGal: A novel ß-galactosidase specific PET tracer for in vivo imaging of tumor senescence

Marcel A. Krueger, Jonathan M. Cotton, Benyuan Zhou, Katharina Wolter, Johannes Schwenck, Anna Kuehn, Kerstin Fuchs, Andreas Maurer, Christian La Fougere, Lars Zender, Bernd J. Pichler

Cancer Res (2019) 79 (13_Supplement): 1146.

https://doi.org/10.1158/1538-7445.AM2019-1146

Published: 01 July 2019

View article titled, Abstract 1146: [18F]FPyGal: A novel ß-galactosidase specific PET tracer for in vivo imaging of tumor senescence

Journal Articles

Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies

Dominik Sonanini, Johannes Schwenck, Julia Schmitt, Andreas Maurer, Sergios Gatidis, Christian Seitz, Gerald Reischl, Manfred Kneilling, Gundram Jung, Peter Lang, Lothar Kanz, Konstantin Nikolaou, Rupert Handgretinger, Christian la Fougère, Bernd J. Pichler

Cancer Res (2018) 78 (13_Supplement): 658.

https://doi.org/10.1158/1538-7445.AM2018-658

Published: 01 July 2018

View article titled, Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies

Journal Articles

Abstract 3034: ¹⁸F-FDG-positron emission tomography (PET)/CT enables the identification of checkpoint inhibitor immunotherapy (CIT) responders by determination of CIT-induced metabolic changes in secondary lymphatic organs

Johannes Schwenck, Barbara Schörg, Francesco Fiz, Kilian Wistuba-Hamprecht, Andrea Forschner, Thomas Eigentler, Benjamin Weide, Claus Garbe, Martin Röcken, Christina Pfannenberg, Bernd J. Pichler, Christian la Fougere, Manfred Kneilling

Cancer Res (2018) 78 (13_Supplement): 3034.

https://doi.org/10.1158/1538-7445.AM2018-3034

Published: 01 July 2018

View article titled, Abstract 3034: 18F-FDG-positron emission tomography (PET)/CT enables the identification of checkpoint inhibitor immunotherapy (CIT) responders by determination of CIT-induced metabolic changes in secondary lymphatic organs

Journal Articles

Abstract LB-369: In vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer

Marcel A. Krueger, Jonathan M. Cotton, Benyuan Zhou, Katharina Wolter, Anna Kuehn, Johannes Schwenck, Kerstin Fuchs, Andreas Maurer, Christian la Fougere, Lars Zender, Bernd Pichler

Cancer Res (2018) 78 (13_Supplement): LB-369.

https://doi.org/10.1158/1538-7445.AM2018-LB-369

Published: 01 July 2018

View article titled, Abstract LB-369: In vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer

Journal Articles

Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study

Cancer Res (2016) 76 (18): 5512–5522.

https://doi.org/10.1158/0008-5472.CAN-15-0642

Published: 15 September 2016

View article titled, Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study

Includes: Supplementary data

NARROW

Abstract LB058: Imaging of CD8⁺ cytotoxic T-cells by Zr-89-Df-IAB22M2C PET/MRI: First clinical experience in patients with metastatic cancer

Abstract 1146: [¹⁸F]FPyGal: A novel ß-galactosidase specific PET tracer for in vivo imaging of tumor senescence

Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies

Abstract 3034: ¹⁸F-FDG-positron emission tomography (PET)/CT enables the identification of checkpoint inhibitor immunotherapy (CIT) responders by determination of CIT-induced metabolic changes in secondary lymphatic organs

Abstract LB-369: In vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer

Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study

Email alerts

AACR Journals

Abstract LB058: Imaging of CD8+ cytotoxic T-cells by Zr-89-Df-IAB22M2C PET/MRI: First clinical experience in patients with metastatic cancer

Abstract 1146: [18F]FPyGal: A novel ß-galactosidase specific PET tracer for in vivo imaging of tumor senescence

Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies

Abstract 3034: 18F-FDG-positron emission tomography (PET)/CT enables the identification of checkpoint inhibitor immunotherapy (CIT) responders by determination of CIT-induced metabolic changes in secondary lymphatic organs

Abstract LB-369: In vivo imaging of tumor senescence with a novel beta-galactosidase specific PET tracer

Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Abstract LB058: Imaging of CD8⁺ cytotoxic T-cells by Zr-89-Df-IAB22M2C PET/MRI: First clinical experience in patients with metastatic cancer

Abstract 1146: [¹⁸F]FPyGal: A novel ß-galactosidase specific PET tracer for in vivo imaging of tumor senescence

Abstract 3034: ¹⁸F-FDG-positron emission tomography (PET)/CT enables the identification of checkpoint inhibitor immunotherapy (CIT) responders by determination of CIT-induced metabolic changes in secondary lymphatic organs